CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
Azithromycindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01178762
NCT01178762N/ACompleted
CompareCT.gov

The Effect of Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis

National Taiwan University Hospital·interventional·Posted Aug 10, 2010·Updated Oct 27, 2010

In Brief

A clinical study evaluating Azithromycin for Chlamydial Conjunctivitis. Completed, enrolled 42 participants across 1 site.

Detailed Summary

Chlamydia trachomatis is one of the major causes of sexually transmitted disease and also the leading infectious cause of blindness in the world.Treatment of C. trachomatis eye infection has involved for a long time. The efficacy of single dose azithromycin has already been demonstrated as effective in the treatment of both trachoma and adult inclusion conjunctivitis.However, in our clinical experience, some patients of chlamydial conjunctivitis may require augmented single dose azithromycin treatments before C. trachomatis is eradicated. In this way, we would like to known the efficacy of single dose and augmented single dose azithromycin in the treatment of chlamydial conjunctivitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChlamydial Conjunctivitis
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 10, 2010
Enrollment StartSep 1, 2007
Primary CompletionNov 1, 2007
Study CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.9 years ago

Interventions

Azithromycindrug

Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis